Stephen E. Abechi

ORCID, self-asserted

ORCID 0000-0002-1875-2361

Publications

Citations

273

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

45 works in the graph, newest first.

In silico–guided design of 2-methylchroman-3-yl formate derivatives targeting PanC as potential anti-tuberculosis agents
2026Letters in Drug Design & DiscoveryJournalOpen access0 citations10.1016/j.lddd.2026.100404
Kernel Naïve Bayes QSAR models for discriminating thyroid hormone receptor agonists and non-agonists among hydroxylated polychlorinated biphenyls
2026Zenodo (CERN European Organization for Nuclear Research)JournalOpen access0 citations10.5281/zenodo.20129139
Kernel Naïve Bayes QSAR models for discriminating thyroid hormone receptor agonists and non-agonists among hydroxylated polychlorinated biphenyls
2026Zenodo (CERN European Organization for Nuclear Research)JournalOpen access0 citations10.5281/zenodo.20129138
Computational design and optimization of INHA inhibitors based on 5-amino-1 H-pyrazole-4-carbonitrile for anti-tuberculosis applications
2026Discover Chemistry.JournalOpen access0 citations10.1007/s44371-026-00706-5
Classification of hydroxylated polychlorinated biphenyls as thyroid hormone receptor agonists and non-agonists using support vector machine–based QSAR models
2026Zenodo (CERN European Organization for Nuclear Research)JournalOpen access0 citations10.5281/zenodo.20133512
Classification of hydroxylated polychlorinated biphenyls as thyroid hormone receptor agonists and non-agonists using support vector machine–based QSAR models
2026Zenodo (CERN European Organization for Nuclear Research)JournalOpen access0 citations10.5281/zenodo.20133511
Design of benzofuro [3,2-d] pyrimidine-based MmpL3 inhibitors as potential anti-tuberculosis agents using integrated in silico approaches
2026In Silico PharmacologyJournalOpen access0 citations10.1007/s40203-026-00646-z
Design and in silico optimization of pyrazolopyridine-based pantothenate synthetase (PanC) inhibitors as novel anti-tuberculosis leads
2026Current Pharmaceutical AnalysisJournalOpen access0 citations10.1016/j.cpan.2026.05.003
Molecular design, ADMET evaluation, and molecular dynamic simulation of some potent sulfonamide-based compounds as anti-tuberculosis agents
2025In Silico Research in BiomedicineJournalOpen access2 citations10.1016/j.insi.2025.100035
Classification of hydroxylated polychlorinated biphenyls as agonists and nonagonists of estrogen receptors using linear discriminant analysis and decision tree models
2025Environmental Toxicology and ChemistryJournal1 citations10.1093/etojnl/vgaf262
In-silico analysis and design of quinoline-based hybrids with oxadiazole and triazole frameworks as anti-diabetic agents
2025Scientific AfricanJournalOpen access1 citations10.1016/j.sciaf.2025.e02631
Structure-based Virtual Screening, and Design of Some Lead Compounds as Inhibitors of Kras-G12D of Pancreatic Cancer
2025Indonesian Journal of Cancer ChemopreventionJournalOpen access0 citations10.14499/indonesianjcanchemoprev15iss2pp108-126
Virtual screening and pharmacokinetics analysis of inhibitors against tuberculosis: Structure and ligand-based approach
2024Scientific AfricanJournalOpen accessFirst author11 citations10.1016/j.sciaf.2024.e02085
Exploring the potential of 2-arylbenzimidazole scaffolds as novel α-amylase inhibitors: QSAR, molecular docking, simulation and pharmacokinetic studies
2024In Silico PharmacologyJournalOpen access10 citations10.1007/s40203-024-00205-4
GREEN SYNTHESIS OF TITANIUM OXIDE (TIO2) NANOPARTICLES USING Phyllanthus Niruri AND ASSESSMENT OF ITS PHYSIOCHEMICAL PARAMETERS IN WASTEWATER TREATMENT
2024Journal of Chemical Society of NigeriaJournalOpen access6 citations10.46602/jcsn.v49i2.965
Green synthesis and characterization of Iron and Zinc nano particles using grape extract
2024Caliphate Journal of Science and TechnologyJournalOpen accessSenior author1 citations10.4314/cajost.v6i3.10
In silico screening, pharmacokinetic, DFT, and dynamics simulation study of ant-hepatitis C virus compounds as potential NS5B Polymerase inhibitors
2024Scientific AfricanJournalOpen access4 citations10.1016/j.sciaf.2024.e02102
Identification of estrogen receptor agonists among hydroxylated polychlorinated biphenyls using classification-based quantitative structure–activity relationship models
2024Current Research in ToxicologyJournalOpen access1 citations10.1016/j.crtox.2024.100158
GREEN SYNTHESIS AND CHARACTERIZATION OF IRON AND ZINC NANO PARTICLES USING GRAPE EXTRACT
2024International Journal of Emerging Multidiciplinaries Biomedical and Clinical ResearchJournalOpen access0 citations10.54938/ijemdbmcr.2024.02.1.323
QSAR, simulation techniques, and ADMET/pharmacokinetics assessment of a set of compounds that target MAO-B as anti-Alzheimer agent
2023Future Journal of Pharmaceutical SciencesJournalOpen accessSenior author18 citations10.1186/s43094-022-00452-2
Cheminformatics study of some indole compounds through QSAR modeling, ADME prediction, molecular docking, and molecular dynamic simulation to identify novel inhibitors of HCV NS5B protease
2023Journal of the Indian Chemical SocietyJournal18 citations10.1016/j.jics.2023.100955
Virtual screening, molecular docking simulation and ADMET prediction of some selected natural products as potential inhibitors of NLRP3 inflammasomes as drug candidates for Alzheimer disease
2023Biocatalysis and Agricultural BiotechnologyJournalSenior author15 citations10.1016/j.bcab.2023.102615
In-silico profiling, design, molecular docking computation, and drug kinetic model evaluation of novel curcumin derivatives as potential anticancer agents
2023Journal of the Indian Chemical SocietyJournal9 citations10.1016/j.jics.2023.100979
Activity prediction, structure-based drug design, molecular docking, and pharmacokinetic studies of 1,4-dihydropyridines derivatives as α-amylase inhibitors
2023Journal of Taibah University Medical SciencesJournalOpen access8 citations10.1016/j.jtumed.2023.12.003
Natural product inhibitors as potential drug candidates against Alzheimer's disease: Structural-based drug design, molecular docking, molecular dynamic simulation experiments, and ADMET predictions
2023Journal of the Indian Chemical SocietyJournal8 citations10.1016/j.jics.2023.100977
In silico screening of potential Tumor necrosis factor alpha (TNF-α) inhibitors through molecular modeling, molecular docking, and pharmacokinetics evaluations
2023Scientific AfricanJournalOpen accessFirst author8 citations10.1016/j.sciaf.2023.e01830
QSAR application of natural therapeutics inhibitors against Alzheimer's disease through in-silico virtual-screening, docking-simulation, molecular dynamics, and pharmacokinetic prediction analysis
2023Intelligent PharmacyJournalOpen access7 citations10.1016/j.ipha.2023.12.004
Chemical bioinformatics study of Nonadec-7-ene-4-carboxylic acid derivatives via molecular docking, and molecular dynamic simulations to identify novel lead inhibitors of hepatitis c virus NS3/4a protease
2023Scientific AfricanJournalOpen access6 citations10.1016/j.sciaf.2023.e01591
Development of binary classification models for grouping hydroxylated polychlorinated biphenyls into active and inactive thyroid hormone receptor agonists
2023SAR and QSAR in environmental researchJournalSenior author6 citations10.1080/1062936x.2023.2207039
Pharmacoinformatics-based strategy in designing and profiling of some Pyrazole analogues as novel hepatitis C virus inhibitors with pharmacokinetic analysis
2023Egyptian Journal of Basic and Applied SciencesJournalOpen access5 citations10.1080/2314808x.2023.2185994
Chemo-informatics applications in the design of novel 7-keto-sempervirol derivatives as SmCB1 inhibitors with potential for treatment of Schistosomiasis
2023HeliyonJournalOpen accessSenior author3 citations10.1016/j.heliyon.2023.e23115
Homology modeling, docking, and ADMET studies of benzoheterocyclic 4-aminoquinolines analogs as inhibitors of Plasmodium falciparum
2023Journal of Taibah University Medical SciencesJournalOpen access2 citations10.1016/j.jtumed.2023.04.005
Development and Validation of Predictive Quantitative Structure–Activity Relationship Models for Estrogenic Activities of Hydroxylated Polychlorinated Biphenyls
2023Environmental Toxicology and ChemistryJournalOpen accessSenior author4 citations10.1002/etc.5566
In-silico studies of some potent hybrid compounds against Alzheimer's disease through virtual screening, simulation techniques, and pharmacokinetic endowment
2023Biocatalysis and Agricultural BiotechnologyJournalSenior author1 citations10.1016/j.bcab.2023.102941
In silico design and pharmacokinetics investigation of some novel hepatitis C virus NS5B inhibitors: pharmacoinformatics approach
2022Bulletin of the National Research Centre/Bulletin of the National Research CenterJournalOpen access24 citations10.1186/s42269-022-00796-y
Structure-Based Drug Design of Novel Piperazine Containing Hydrazone Derivatives as Potent Alzheimer Inhibitors: Molecular Docking and Drug Kinetics Evaluation
2022Brain DisordersJournalOpen accessSenior author18 citations10.1016/j.dscb.2022.100041
Ligand-based drug design, molecular docking and pharmacokinetic studies of some series of 1,4 - dihydropyridines derivatives as human intestinal maltase-glucoamylase inhibitor
2022Chemical Data CollectionsJournal14 citations10.1016/j.cdc.2022.100911
Virtual screening and molecular dynamic simulations of the antimalarial derivatives of 2-anilino 4-amino substituted quinazolines docked against a Pf-DHODH protein target
2022Egyptian Journal of Medical Human GeneticsJournalOpen access12 citations10.1186/s43042-022-00329-2
2D QSAR, design, docking study and ADMET of some N-aryl derivatives concerning inhibitory activity against Alzheimer disease
2022Future Journal of Pharmaceutical SciencesJournalOpen accessSenior author13 citations10.1186/s43094-022-00420-w
Structure-based design, drug-likeness, and pharmacokinetic studies of novel substituted pyrimidine derivatives as potent HCV NS3/A4 protease inhibitors
2022Biocatalysis and Agricultural BiotechnologyJournal12 citations10.1016/j.bcab.2022.102539
QSAR, Molecular Docking, Dynamic Simulation and Kinetic Study of Monoamine Oxidase B Inhibitors as Anti-Alzheimer Agent
2022Chemistry AfricaJournalSenior author7 citations10.1007/s42250-022-00561-8
Quantitative Structure-Activity Relationship, Structure-based Design, and ADMET studies of pyrimethamine and cycloguanil analogs inhibitors of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase (PfDHFR-TS).
2022Chemical Physics ImpactJournalOpen access8 citations10.1016/j.chphi.2022.100132
Molecular Docking, Drug-Likeness and SwissADME Evaluations of the Interactions of 2’-Substituted Triclosan Derivatives with Plasmodium falciparum Enoyl-Acyl Carrier Protein Reductase
2022Malaysian Journal of Pharmaceutical SciencesJournalOpen access3 citations10.21315/mjps2022.20.2.5
Computational and pharmacokinetics studies of 1,3-dimethylbenzimidazolinone analogues of new proposed agent against Alzheimer's disease
2022Beni-Suef University Journal of Basic and Applied SciencesJournalOpen accessSenior author4 citations10.1186/s43088-022-00231-1
Quantitative structure–activity relationship modeling of hydroxylated polychlorinated biphenyls as constitutive androstane receptor agonists
2022Structural ChemistryJournalSenior author3 citations10.1007/s11224-022-01992-2